See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: Jan. 6, 2004

Amyotrophic Lateral Sclerosis (ALS) Mantle Cell Lymphoma Anemia

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Amyotrophic Lateral Sclerosis (ALS)

A research study to test the safety, tolerability, and effectiveness of an investigational medication in patients with amyotrophic lateral sclerosis (ALS, or Lou Gehrig's disease). Volunteers 21 to 80 who have a confirmed diagnosis of ALS may be eligible. Research site located in Kansas City, Kan.

More Information

Please see http://www.centerwatch.com/patient/studies/cat160.html.

-----

Mantle Cell Lymphoma

A research study of an investigational medication for Mantle Cell Lymphoma. Volunteers at least 18 or older who have documented relapsed or refractory Mantle Cell Lymphoma following at least 1 or more prior therapies and who have adequate organ function may be eligible. Research site located in Iowa City, Iowa.

More Information

Please see http://www.centerwatch.com/patient/studies/cat628.html.

-----

Anemia

An experimental study for treating anemia in cancer subjects. Volunteers 18 or older who have anemia resulting from cancer, chemotherapy, or radiotherapy, who are stable for 1 month before the study starts and have a life expectancy of 9 months or greater based on the judgment of the investigator may be eligible. Research site located in Jamaica, NY.

More Information

Please see http://www.centerwatch.com/patient/studies/cat373.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News